|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:ACSF2-HSF5 (FusionGDB2 ID:1485) |
Fusion Gene Summary for ACSF2-HSF5 |
Fusion gene summary |
Fusion gene information | Fusion gene name: ACSF2-HSF5 | Fusion gene ID: 1485 | Hgene | Tgene | Gene symbol | ACSF2 | HSF5 | Gene ID | 80221 | 124535 |
Gene name | acyl-CoA synthetase family member 2 | heat shock transcription factor 5 | |
Synonyms | ACSMW|AVYV493 | HSF 5|HSTF 5 | |
Cytomap | 17q21.33 | 17q22 | |
Type of gene | protein-coding | protein-coding | |
Description | medium-chain acyl-CoA ligase ACSF2, mitochondrialPPARG binding, long chain fatty acid acyl Co-A ligase likeacyl-CoA synthetase family member 2, mitochondrial | heat shock factor protein 5heat shock transcription factor family member 5 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q96CM8 | Q4G112 | |
Ensembl transtripts involved in fusion gene | ENST00000541920, ENST00000300441, ENST00000427954, ENST00000502667, ENST00000504392, ENST00000506085, | ENST00000323777, | |
Fusion gene scores | * DoF score | 6 X 4 X 4=96 | 7 X 4 X 6=168 |
# samples | 6 | 8 | |
** MAII score | log2(6/96*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/168*10)=-1.0703893278914 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ACSF2 [Title/Abstract] AND HSF5 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ACSF2(48503750)-HSF5(56499791), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene breakpoints across ACSF2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across HSF5 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-BR-8295-01A | ACSF2 | chr17 | 48503750 | + | HSF5 | chr17 | 56499791 | - |
Top |
Fusion Gene ORF analysis for ACSF2-HSF5 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5UTR-3CDS | ENST00000541920 | ENST00000323777 | ACSF2 | chr17 | 48503750 | + | HSF5 | chr17 | 56499791 | - |
In-frame | ENST00000300441 | ENST00000323777 | ACSF2 | chr17 | 48503750 | + | HSF5 | chr17 | 56499791 | - |
In-frame | ENST00000427954 | ENST00000323777 | ACSF2 | chr17 | 48503750 | + | HSF5 | chr17 | 56499791 | - |
In-frame | ENST00000502667 | ENST00000323777 | ACSF2 | chr17 | 48503750 | + | HSF5 | chr17 | 56499791 | - |
In-frame | ENST00000504392 | ENST00000323777 | ACSF2 | chr17 | 48503750 | + | HSF5 | chr17 | 56499791 | - |
intron-3CDS | ENST00000506085 | ENST00000323777 | ACSF2 | chr17 | 48503750 | + | HSF5 | chr17 | 56499791 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000300441 | ACSF2 | chr17 | 48503750 | + | ENST00000323777 | HSF5 | chr17 | 56499791 | - | 2496 | 232 | 35 | 313 | 92 |
ENST00000504392 | ACSF2 | chr17 | 48503750 | + | ENST00000323777 | HSF5 | chr17 | 56499791 | - | 2436 | 172 | 44 | 253 | 69 |
ENST00000427954 | ACSF2 | chr17 | 48503750 | + | ENST00000323777 | HSF5 | chr17 | 56499791 | - | 2435 | 171 | 43 | 252 | 69 |
ENST00000502667 | ACSF2 | chr17 | 48503750 | + | ENST00000323777 | HSF5 | chr17 | 56499791 | - | 2402 | 138 | 10 | 219 | 69 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000300441 | ENST00000323777 | ACSF2 | chr17 | 48503750 | + | HSF5 | chr17 | 56499791 | - | 0.8072346 | 0.19276544 |
ENST00000504392 | ENST00000323777 | ACSF2 | chr17 | 48503750 | + | HSF5 | chr17 | 56499791 | - | 0.89806235 | 0.10193765 |
ENST00000427954 | ENST00000323777 | ACSF2 | chr17 | 48503750 | + | HSF5 | chr17 | 56499791 | - | 0.8785906 | 0.12140946 |
ENST00000502667 | ENST00000323777 | ACSF2 | chr17 | 48503750 | + | HSF5 | chr17 | 56499791 | - | 0.7103139 | 0.28968605 |
Top |
Fusion Genomic Features for ACSF2-HSF5 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for ACSF2-HSF5 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:48503750/chr17:56499791) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
ACSF2 | HSF5 |
FUNCTION: Acyl-CoA synthases catalyze the initial reaction in fatty acid metabolism, by forming a thioester with CoA (PubMed:17762044). Has some preference toward medium-chain substrates (PubMed:17762044). Plays a role in adipocyte differentiation (PubMed:16380219). {ECO:0000269|PubMed:16380219, ECO:0000269|PubMed:17762044}. | FUNCTION: May act as a transcriptional factor. {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ACSF2 | chr17:48503750 | chr17:56499791 | ENST00000300441 | + | 1 | 16 | 263_271 | 42 | 616.0 | Nucleotide binding | ATP |
Tgene | HSF5 | chr17:48503750 | chr17:56499791 | ENST00000323777 | 4 | 6 | 10_200 | 573 | 597.0 | DNA binding | Ontology_term=ECO:0000250 |
Top |
Fusion Gene Sequence for ACSF2-HSF5 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>1485_1485_1_ACSF2-HSF5_ACSF2_chr17_48503750_ENST00000300441_HSF5_chr17_56499791_ENST00000323777_length(transcript)=2496nt_BP=232nt ATAGGCAGAGGCCACCCTCCCCGCCTCCCCGCCCGCTGCGCGCCCGCCCCGCCCCGGCTCACTTTAAAAGTTTACTCGGGCCGGGACGCA GGGCAAAGCGAGCCATGGCTGTCTACGTCGGGATGCTGCGCCTGGGGAGGCTGTGCGCCGGGAGCTCGGGGGTGCTGGGGGCCCGGGCCG CCCTCTCTCGGAGTTGGCAGGAAGCCAGGTTGCAGGGTGTCCGCTTCCTCAGATCTTCATCTGCTGGTGGACGTGGCCTGCAAGCAGGAG CGCTTTCCAAAGGAGGAAGAATTAAAAGAGTGAGGAATGGATGACAAATGTGACATTGTGCACTAGCTGTAGCTGGAGGCAGACTAGCCT TGCACATGACAAACTGTTGGGATTTTTTCAGTTCTGTTAAGGAAAAAAAAGTATTTTTTGTTTCGTTAATTGAGAATTTTGTTAATTGAG AATTGGGAATTTGTATGTACTACAGTGGTTCAGTTCAGATTATCTGCCTTGACAAACTACTGAACATCTAGCAGCCACGTTTTTTGGCTG CCCAGATCCCTTTTAAATGAAAAGTTCTGACCTTCTGTTATAGTCAAGGAGCATCTAAAAACTGCTCCATCTATGGTACTAAGAATAATC TGTGTGTGTGCTGATTTGTTGTCTTGCCACTCAAACTGTAGTCAGCACAACTTTAGTGGGGAATTCAGTCTCTCTGATTCAAGTCACAGT GTGATCCTTTTAGAGGAGATTGTGTGAGAAACAAAGGCATGTGAGGTCACCAGCATCACAGGTCTAAATGCATCAGGAATTCCAGGGAAG AAACTCTGGAGAAGAGCTAATTTTCTAAGTGATTAACCAGGAAATTCTCTTACTTCCTAACCCAGCATTCTGTTTTAAGAGCAAGGCATC CGGACTTGGACCATCTATCACACTTAACAGCCCCTGATTCTTTTATATTAATGGAAGCATTCTTCTATTTTCATATCTTTCTTTAATTTT AATGATACATTATCATAAATGGTAAAAAGATTTTATTAATATATCACTTATTTAAATGTCTTTAAAGAAAGTATTTAACTTGTTTAATAT AATTGTATTTATAAATGCTGATAGATTTAAAGGTTTTAAAGTTTTATATTTTTATTATTGCAGGATAGAAGGATAAAGGATGCATGTGTA GTATTTTTATTTTGAAAGGAAAATGTACAATGTGTGAACAAAAACATTAAGAGATTTAATATACTATTTTCTTATTTTAGATTTTTACAT TCAATAAGTATAAATTCTCATCTATATAAGGTATTGTGTGCAAATTTGGGAAAAAACTGATTAGCAGCCATTTAGTAGAAGCTATGCCTC TGATTTTTAAAGAATGGTTTCAATCTGGTTTAAGCTTCTGAGAGAATTTTGGATAATGGGATAGATGGTAACATTTTTTTCTTATCCCTG TTACAGGATTCTAGATTTGTGCAGTAGGATTGTGGGACTGTGTTTTAGGAGAGAAGGATGTCTTGGATGTCCAGTTTCTGTGGTTAATCC CTTACTTGCTTATCCAGTGACAGCAAGAAACTTTCTGATTTAAAGTCTTTCAATTGACCAAAACTTTCTTATTGGATTCTGTTTCAGTTC TCCTATTAAGCACTGCAGAAACGAAAGGAAAGCCTAGGAATATGAAACTAATTAAAAAGGCACTTGGTGATATGACATAGTACTATGCTA GCCGTTGTGGATGTAACAGTTCATTTCTTATACTGCATTGTGCCTTCCCAATGATGTCAAACCCTAGAAATATTACAGAGATCTACTTTT CTGGAAAAGGGTGAGCTCTGTATTGATCTGCAGTGACTCTGTTTAGATATTAAAGTAGGTTCTGAAAAGCGACCTGTGTGGTCCCTCTGA TTAGACTAGTTAATGTCTATGTGATGGGCATTTATTTATCTTTATTAGCAAGGTTTAAAAGAGCAAATTATCAAGACACCTATATCTTTT GGCCAGACTATATAATATTTTGTCAGAGTATGTGAAGAGGAGACCCAATTTCCAAATGAAGGAACTTTGCTTTTTCTCTGTCATGTTGAA GAGCTAATATACTGTGTAGATTTTCCCCTAAATATGGCTTTCTTAGCTTTATAGATGTTGAGATAATATCTTTTGAGGAACACATGTCAA GCAGGAACCTTGGCATAGATTTGGTTTCAGTTGTTTTAAGGCTTAATTAATGAAATGCCTTAATCAGCTTTCCAAACATTTTTATATATG AATACAGCAGACCAAGGAGCTGGATCTCCTGCTATCCTTACACGCCTTGTATCTATCAACTAAAGCTGTCATTAATGACTTGGGCAAAAT GGCAAGAGGTATAATAAAGTCTTCCTGTGAATTAGCCAGTAGGGTCTGACACAACTAGTCAACTAACAAGGTTCCTGACTAGTACCTCAG >1485_1485_1_ACSF2-HSF5_ACSF2_chr17_48503750_ENST00000300441_HSF5_chr17_56499791_ENST00000323777_length(amino acids)=92AA_BP=65 MRARPAPAHFKSLLGPGRRAKRAMAVYVGMLRLGRLCAGSSGVLGARAALSRSWQEARLQGVRFLRSSSAGGRGLQAGALSKGGRIKRVR -------------------------------------------------------------- >1485_1485_2_ACSF2-HSF5_ACSF2_chr17_48503750_ENST00000427954_HSF5_chr17_56499791_ENST00000323777_length(transcript)=2435nt_BP=171nt CTTTAAAAGTTTACTCGGGCCGGGACGCAGGGCAAAGCGAGCCATGGCTGTCTACGTCGGGATGCTGCGCCTGGGGAGGCTGTGCGCCGG GAGCTCGGGGGTGCTGGGGGCCCGGGCCGCCCTCTCTCGGAGTTGGCAGGAAGCCAGGTTGCAGGGTGTCCGCTTCCTCAGATCTTCATC TGCTGGTGGACGTGGCCTGCAAGCAGGAGCGCTTTCCAAAGGAGGAAGAATTAAAAGAGTGAGGAATGGATGACAAATGTGACATTGTGC ACTAGCTGTAGCTGGAGGCAGACTAGCCTTGCACATGACAAACTGTTGGGATTTTTTCAGTTCTGTTAAGGAAAAAAAAGTATTTTTTGT TTCGTTAATTGAGAATTTTGTTAATTGAGAATTGGGAATTTGTATGTACTACAGTGGTTCAGTTCAGATTATCTGCCTTGACAAACTACT GAACATCTAGCAGCCACGTTTTTTGGCTGCCCAGATCCCTTTTAAATGAAAAGTTCTGACCTTCTGTTATAGTCAAGGAGCATCTAAAAA CTGCTCCATCTATGGTACTAAGAATAATCTGTGTGTGTGCTGATTTGTTGTCTTGCCACTCAAACTGTAGTCAGCACAACTTTAGTGGGG AATTCAGTCTCTCTGATTCAAGTCACAGTGTGATCCTTTTAGAGGAGATTGTGTGAGAAACAAAGGCATGTGAGGTCACCAGCATCACAG GTCTAAATGCATCAGGAATTCCAGGGAAGAAACTCTGGAGAAGAGCTAATTTTCTAAGTGATTAACCAGGAAATTCTCTTACTTCCTAAC CCAGCATTCTGTTTTAAGAGCAAGGCATCCGGACTTGGACCATCTATCACACTTAACAGCCCCTGATTCTTTTATATTAATGGAAGCATT CTTCTATTTTCATATCTTTCTTTAATTTTAATGATACATTATCATAAATGGTAAAAAGATTTTATTAATATATCACTTATTTAAATGTCT TTAAAGAAAGTATTTAACTTGTTTAATATAATTGTATTTATAAATGCTGATAGATTTAAAGGTTTTAAAGTTTTATATTTTTATTATTGC AGGATAGAAGGATAAAGGATGCATGTGTAGTATTTTTATTTTGAAAGGAAAATGTACAATGTGTGAACAAAAACATTAAGAGATTTAATA TACTATTTTCTTATTTTAGATTTTTACATTCAATAAGTATAAATTCTCATCTATATAAGGTATTGTGTGCAAATTTGGGAAAAAACTGAT TAGCAGCCATTTAGTAGAAGCTATGCCTCTGATTTTTAAAGAATGGTTTCAATCTGGTTTAAGCTTCTGAGAGAATTTTGGATAATGGGA TAGATGGTAACATTTTTTTCTTATCCCTGTTACAGGATTCTAGATTTGTGCAGTAGGATTGTGGGACTGTGTTTTAGGAGAGAAGGATGT CTTGGATGTCCAGTTTCTGTGGTTAATCCCTTACTTGCTTATCCAGTGACAGCAAGAAACTTTCTGATTTAAAGTCTTTCAATTGACCAA AACTTTCTTATTGGATTCTGTTTCAGTTCTCCTATTAAGCACTGCAGAAACGAAAGGAAAGCCTAGGAATATGAAACTAATTAAAAAGGC ACTTGGTGATATGACATAGTACTATGCTAGCCGTTGTGGATGTAACAGTTCATTTCTTATACTGCATTGTGCCTTCCCAATGATGTCAAA CCCTAGAAATATTACAGAGATCTACTTTTCTGGAAAAGGGTGAGCTCTGTATTGATCTGCAGTGACTCTGTTTAGATATTAAAGTAGGTT CTGAAAAGCGACCTGTGTGGTCCCTCTGATTAGACTAGTTAATGTCTATGTGATGGGCATTTATTTATCTTTATTAGCAAGGTTTAAAAG AGCAAATTATCAAGACACCTATATCTTTTGGCCAGACTATATAATATTTTGTCAGAGTATGTGAAGAGGAGACCCAATTTCCAAATGAAG GAACTTTGCTTTTTCTCTGTCATGTTGAAGAGCTAATATACTGTGTAGATTTTCCCCTAAATATGGCTTTCTTAGCTTTATAGATGTTGA GATAATATCTTTTGAGGAACACATGTCAAGCAGGAACCTTGGCATAGATTTGGTTTCAGTTGTTTTAAGGCTTAATTAATGAAATGCCTT AATCAGCTTTCCAAACATTTTTATATATGAATACAGCAGACCAAGGAGCTGGATCTCCTGCTATCCTTACACGCCTTGTATCTATCAACT AAAGCTGTCATTAATGACTTGGGCAAAATGGCAAGAGGTATAATAAAGTCTTCCTGTGAATTAGCCAGTAGGGTCTGACACAACTAGTCA ACTAACAAGGTTCCTGACTAGTACCTCAGTATTTCAGCACCTTAAGCACTGATAAATTTCAATCAGTCAACAATAAAGTGAGTGTTCCAA >1485_1485_2_ACSF2-HSF5_ACSF2_chr17_48503750_ENST00000427954_HSF5_chr17_56499791_ENST00000323777_length(amino acids)=69AA_BP=42 -------------------------------------------------------------- >1485_1485_3_ACSF2-HSF5_ACSF2_chr17_48503750_ENST00000502667_HSF5_chr17_56499791_ENST00000323777_length(transcript)=2402nt_BP=138nt AAAGCGAGCCATGGCTGTCTACGTCGGGATGCTGCGCCTGGGGAGGCTGTGCGCCGGGAGCTCGGGGGTGCTGGGGGCCCGGGCCGCCCT CTCTCGGAGTTGGCAGGAAGCCAGGTTGCAGGGTGTCCGCTTCCTCAGATCTTCATCTGCTGGTGGACGTGGCCTGCAAGCAGGAGCGCT TTCCAAAGGAGGAAGAATTAAAAGAGTGAGGAATGGATGACAAATGTGACATTGTGCACTAGCTGTAGCTGGAGGCAGACTAGCCTTGCA CATGACAAACTGTTGGGATTTTTTCAGTTCTGTTAAGGAAAAAAAAGTATTTTTTGTTTCGTTAATTGAGAATTTTGTTAATTGAGAATT GGGAATTTGTATGTACTACAGTGGTTCAGTTCAGATTATCTGCCTTGACAAACTACTGAACATCTAGCAGCCACGTTTTTTGGCTGCCCA GATCCCTTTTAAATGAAAAGTTCTGACCTTCTGTTATAGTCAAGGAGCATCTAAAAACTGCTCCATCTATGGTACTAAGAATAATCTGTG TGTGTGCTGATTTGTTGTCTTGCCACTCAAACTGTAGTCAGCACAACTTTAGTGGGGAATTCAGTCTCTCTGATTCAAGTCACAGTGTGA TCCTTTTAGAGGAGATTGTGTGAGAAACAAAGGCATGTGAGGTCACCAGCATCACAGGTCTAAATGCATCAGGAATTCCAGGGAAGAAAC TCTGGAGAAGAGCTAATTTTCTAAGTGATTAACCAGGAAATTCTCTTACTTCCTAACCCAGCATTCTGTTTTAAGAGCAAGGCATCCGGA CTTGGACCATCTATCACACTTAACAGCCCCTGATTCTTTTATATTAATGGAAGCATTCTTCTATTTTCATATCTTTCTTTAATTTTAATG ATACATTATCATAAATGGTAAAAAGATTTTATTAATATATCACTTATTTAAATGTCTTTAAAGAAAGTATTTAACTTGTTTAATATAATT GTATTTATAAATGCTGATAGATTTAAAGGTTTTAAAGTTTTATATTTTTATTATTGCAGGATAGAAGGATAAAGGATGCATGTGTAGTAT TTTTATTTTGAAAGGAAAATGTACAATGTGTGAACAAAAACATTAAGAGATTTAATATACTATTTTCTTATTTTAGATTTTTACATTCAA TAAGTATAAATTCTCATCTATATAAGGTATTGTGTGCAAATTTGGGAAAAAACTGATTAGCAGCCATTTAGTAGAAGCTATGCCTCTGAT TTTTAAAGAATGGTTTCAATCTGGTTTAAGCTTCTGAGAGAATTTTGGATAATGGGATAGATGGTAACATTTTTTTCTTATCCCTGTTAC AGGATTCTAGATTTGTGCAGTAGGATTGTGGGACTGTGTTTTAGGAGAGAAGGATGTCTTGGATGTCCAGTTTCTGTGGTTAATCCCTTA CTTGCTTATCCAGTGACAGCAAGAAACTTTCTGATTTAAAGTCTTTCAATTGACCAAAACTTTCTTATTGGATTCTGTTTCAGTTCTCCT ATTAAGCACTGCAGAAACGAAAGGAAAGCCTAGGAATATGAAACTAATTAAAAAGGCACTTGGTGATATGACATAGTACTATGCTAGCCG TTGTGGATGTAACAGTTCATTTCTTATACTGCATTGTGCCTTCCCAATGATGTCAAACCCTAGAAATATTACAGAGATCTACTTTTCTGG AAAAGGGTGAGCTCTGTATTGATCTGCAGTGACTCTGTTTAGATATTAAAGTAGGTTCTGAAAAGCGACCTGTGTGGTCCCTCTGATTAG ACTAGTTAATGTCTATGTGATGGGCATTTATTTATCTTTATTAGCAAGGTTTAAAAGAGCAAATTATCAAGACACCTATATCTTTTGGCC AGACTATATAATATTTTGTCAGAGTATGTGAAGAGGAGACCCAATTTCCAAATGAAGGAACTTTGCTTTTTCTCTGTCATGTTGAAGAGC TAATATACTGTGTAGATTTTCCCCTAAATATGGCTTTCTTAGCTTTATAGATGTTGAGATAATATCTTTTGAGGAACACATGTCAAGCAG GAACCTTGGCATAGATTTGGTTTCAGTTGTTTTAAGGCTTAATTAATGAAATGCCTTAATCAGCTTTCCAAACATTTTTATATATGAATA CAGCAGACCAAGGAGCTGGATCTCCTGCTATCCTTACACGCCTTGTATCTATCAACTAAAGCTGTCATTAATGACTTGGGCAAAATGGCA AGAGGTATAATAAAGTCTTCCTGTGAATTAGCCAGTAGGGTCTGACACAACTAGTCAACTAACAAGGTTCCTGACTAGTACCTCAGTATT >1485_1485_3_ACSF2-HSF5_ACSF2_chr17_48503750_ENST00000502667_HSF5_chr17_56499791_ENST00000323777_length(amino acids)=69AA_BP=42 -------------------------------------------------------------- >1485_1485_4_ACSF2-HSF5_ACSF2_chr17_48503750_ENST00000504392_HSF5_chr17_56499791_ENST00000323777_length(transcript)=2436nt_BP=172nt ACTTTAAAAGTTTACTCGGGCCGGGACGCAGGGCAAAGCGAGCCATGGCTGTCTACGTCGGGATGCTGCGCCTGGGGAGGCTGTGCGCCG GGAGCTCGGGGGTGCTGGGGGCCCGGGCCGCCCTCTCTCGGAGTTGGCAGGAAGCCAGGTTGCAGGGTGTCCGCTTCCTCAGATCTTCAT CTGCTGGTGGACGTGGCCTGCAAGCAGGAGCGCTTTCCAAAGGAGGAAGAATTAAAAGAGTGAGGAATGGATGACAAATGTGACATTGTG CACTAGCTGTAGCTGGAGGCAGACTAGCCTTGCACATGACAAACTGTTGGGATTTTTTCAGTTCTGTTAAGGAAAAAAAAGTATTTTTTG TTTCGTTAATTGAGAATTTTGTTAATTGAGAATTGGGAATTTGTATGTACTACAGTGGTTCAGTTCAGATTATCTGCCTTGACAAACTAC TGAACATCTAGCAGCCACGTTTTTTGGCTGCCCAGATCCCTTTTAAATGAAAAGTTCTGACCTTCTGTTATAGTCAAGGAGCATCTAAAA ACTGCTCCATCTATGGTACTAAGAATAATCTGTGTGTGTGCTGATTTGTTGTCTTGCCACTCAAACTGTAGTCAGCACAACTTTAGTGGG GAATTCAGTCTCTCTGATTCAAGTCACAGTGTGATCCTTTTAGAGGAGATTGTGTGAGAAACAAAGGCATGTGAGGTCACCAGCATCACA GGTCTAAATGCATCAGGAATTCCAGGGAAGAAACTCTGGAGAAGAGCTAATTTTCTAAGTGATTAACCAGGAAATTCTCTTACTTCCTAA CCCAGCATTCTGTTTTAAGAGCAAGGCATCCGGACTTGGACCATCTATCACACTTAACAGCCCCTGATTCTTTTATATTAATGGAAGCAT TCTTCTATTTTCATATCTTTCTTTAATTTTAATGATACATTATCATAAATGGTAAAAAGATTTTATTAATATATCACTTATTTAAATGTC TTTAAAGAAAGTATTTAACTTGTTTAATATAATTGTATTTATAAATGCTGATAGATTTAAAGGTTTTAAAGTTTTATATTTTTATTATTG CAGGATAGAAGGATAAAGGATGCATGTGTAGTATTTTTATTTTGAAAGGAAAATGTACAATGTGTGAACAAAAACATTAAGAGATTTAAT ATACTATTTTCTTATTTTAGATTTTTACATTCAATAAGTATAAATTCTCATCTATATAAGGTATTGTGTGCAAATTTGGGAAAAAACTGA TTAGCAGCCATTTAGTAGAAGCTATGCCTCTGATTTTTAAAGAATGGTTTCAATCTGGTTTAAGCTTCTGAGAGAATTTTGGATAATGGG ATAGATGGTAACATTTTTTTCTTATCCCTGTTACAGGATTCTAGATTTGTGCAGTAGGATTGTGGGACTGTGTTTTAGGAGAGAAGGATG TCTTGGATGTCCAGTTTCTGTGGTTAATCCCTTACTTGCTTATCCAGTGACAGCAAGAAACTTTCTGATTTAAAGTCTTTCAATTGACCA AAACTTTCTTATTGGATTCTGTTTCAGTTCTCCTATTAAGCACTGCAGAAACGAAAGGAAAGCCTAGGAATATGAAACTAATTAAAAAGG CACTTGGTGATATGACATAGTACTATGCTAGCCGTTGTGGATGTAACAGTTCATTTCTTATACTGCATTGTGCCTTCCCAATGATGTCAA ACCCTAGAAATATTACAGAGATCTACTTTTCTGGAAAAGGGTGAGCTCTGTATTGATCTGCAGTGACTCTGTTTAGATATTAAAGTAGGT TCTGAAAAGCGACCTGTGTGGTCCCTCTGATTAGACTAGTTAATGTCTATGTGATGGGCATTTATTTATCTTTATTAGCAAGGTTTAAAA GAGCAAATTATCAAGACACCTATATCTTTTGGCCAGACTATATAATATTTTGTCAGAGTATGTGAAGAGGAGACCCAATTTCCAAATGAA GGAACTTTGCTTTTTCTCTGTCATGTTGAAGAGCTAATATACTGTGTAGATTTTCCCCTAAATATGGCTTTCTTAGCTTTATAGATGTTG AGATAATATCTTTTGAGGAACACATGTCAAGCAGGAACCTTGGCATAGATTTGGTTTCAGTTGTTTTAAGGCTTAATTAATGAAATGCCT TAATCAGCTTTCCAAACATTTTTATATATGAATACAGCAGACCAAGGAGCTGGATCTCCTGCTATCCTTACACGCCTTGTATCTATCAAC TAAAGCTGTCATTAATGACTTGGGCAAAATGGCAAGAGGTATAATAAAGTCTTCCTGTGAATTAGCCAGTAGGGTCTGACACAACTAGTC AACTAACAAGGTTCCTGACTAGTACCTCAGTATTTCAGCACCTTAAGCACTGATAAATTTCAATCAGTCAACAATAAAGTGAGTGTTCCA >1485_1485_4_ACSF2-HSF5_ACSF2_chr17_48503750_ENST00000504392_HSF5_chr17_56499791_ENST00000323777_length(amino acids)=69AA_BP=42 -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for ACSF2-HSF5 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ACSF2-HSF5 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ACSF2-HSF5 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |